Results 221 to 230 of about 145,670 (398)

Diagnosis of Gastroesophageal Reflux Disease (GERD) in Otorhinolaryngology

open access: bronze, 2000
Takashi Kato   +4 more
openalex   +2 more sources

Post‐Thyroidectomy Opioid Prescription and Risk of Persistent Opioid Use: A Propensity Matched Cohort Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background This study evaluates the risk of persistent opioid use (POU) among thyroidectomy patients given postoperative opioids. Methods Patients undergoing thyroidectomy were identified using the TriNetX Research Platform (2010–2024). Cohorts were divided based on opioid prescriptions on the day of surgery.
Oluwatobiloba Ayo‐Ajibola   +4 more
wiley   +1 more source

Predatory journals in otorhinolaryngology

open access: yesEuropean Annals of Otorhinolaryngology, Head and Neck Diseases, 2020
Ollivier Laccourreye, H. Maisonneuve
openaire   +3 more sources

Detection of Circulating Cancer‐Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma and Their Impact on Circulating Tumor Cells

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Like tumor cells, cancer‐associated fibroblasts (CAFs) can enter the bloodstream and may function in systemic circulation. Methods Circulating CAFs (cCAFs) were isolated from the peripheral blood of head and neck squamous cell carcinoma (HNSCC) patients using CD45 depletion and detected by FAP expression using RT‐qPCR.
Kazuaki Chikamatsu   +6 more
wiley   +1 more source

Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic

open access: yesAmerican Journal of Otolaryngology, 2020
M. Khan, S. Parab, M. Paranjape
semanticscholar   +1 more source

Prophylactic Versus Reactive (PvR) Feeding in Patients Undergoing (Chemo)radiation in Head and Neck Cancers: Results of a Phase III Randomized Controlled Trial

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Optimal feeding strategy (Prophylactic vs. Reactive) during Radiation Therapy (RT) for Head and Neck Cancers (HNC) remains to be established. Methods This phase III trial randomized (1:1) patients of HNC to prophylactic [nasogastric tube (NGT) placed at least 1 day before RT starting] versus reactive arm (NGT when required).
Sarbani Ghosh Laskar   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy